Form 4: Surrozen Executive Vice President, Research, Yang Li, Acquires 35,000 Stock Options
SEC Form 4
Yang Li, Executive Vice President of Research at Surrozen, Inc., acquired 35,000 stock options on January 17, 2025, which vest monthly starting February 1, 2025.
Summary
- Yang Li, the Executive Vice President of Research at Surrozen, Inc., was granted 35,000 stock options on January 17, 2025.
- These options have an exercise price of $12.08 per share.
- The options vest in 48 equal monthly installments, beginning on February 1, 2025.
- The vesting is contingent upon Mr. Li's continued employment with Surrozen.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally positive for aligning management and shareholder interests. There are no negative implications.
Positives
- The grant of stock options to a key executive like Yang Li aligns his interests with the long-term success of the company.
- The vesting schedule encourages continued service and commitment from the executive.
Risks
- The value of the options is dependent on the future performance of Surrozen's stock price.
- If Mr. Li leaves the company before the options fully vest, he may forfeit some or all of the options.
Future Outlook
The options will vest over the next 48 months, contingent on continued service.
Industry Context
Stock option grants are a common form of compensation for executives in the biotechnology industry, aligning their interests with shareholders and incentivizing long-term growth.
Comparison to Industry Standards
- Stock option grants are a standard practice in the biotech industry to attract and retain key talent.
- The vesting schedule of 48 months is typical for executive stock options.
- The exercise price of $12.08 is specific to Surrozen's stock and market conditions at the time of the grant.
Stakeholder Impact
- Shareholders may view this as a positive sign of management's commitment to the company.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 01/17/2025 | Date of the stock option grant to Yang Li. |
| 02/01/2025 | Start date for the monthly vesting of the stock options. |
| 01/17/2035 | Expiration date of the stock options. |
| 01/22/2025 | Date the Form 4 was signed. |
Keywords
stock options, insider trading, executive compensation, Surrozen, Yang Li, SRZN, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.